BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 21753790)

  • 1. Advances in sarcoma genomics and new therapeutic targets.
    Taylor BS; Barretina J; Maki RG; Antonescu CR; Singer S; Ladanyi M
    Nat Rev Cancer; 2011 Jul; 11(8):541-57. PubMed ID: 21753790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in sarcoma gene mutations and therapeutic targets.
    Gao P; Seebacher NA; Hornicek F; Guo Z; Duan Z
    Cancer Treat Rev; 2018 Jan; 62():98-109. PubMed ID: 29190505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of soft-tissue sarcomas: translation of biological advances into treatment measures.
    Hoang NT; Acevedo LA; Mann MJ; Tolani B
    Cancer Manag Res; 2018; 10():1089-1114. PubMed ID: 29785138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
    Ryan CW; Desai J
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel treatment targets in sarcoma: more than just the GIST.
    Shoushtari AN; Van Tine BA; Schwartz GK
    Am Soc Clin Oncol Educ Book; 2014; ():e488-95. PubMed ID: 24857144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
    Aragon-Ching JB; Maki RG
    Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
    Riedel RF
    Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapies for sarcomas: new roles for the pathologist.
    Al-Zaid T; Somaiah N; Lazar AJ
    Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of sarcomagenesis.
    Matushansky I; Maki RG
    Hematol Oncol Clin North Am; 2005 Jun; 19(3):427-49, v. PubMed ID: 15939190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the genomics of soft tissue sarcomas.
    Conley AP; Trent J; Zhang W
    Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 in bone and soft tissue sarcomas.
    Thoenen E; Curl A; Iwakuma T
    Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
    Todd R; Lunec J
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting sarcomas: therapeutic targets and their rational.
    Ordóñez JL; Martins AS; Osuna D; Madoz-Gúrpide J; de Alava E
    Semin Diagn Pathol; 2008 Nov; 25(4):304-16. PubMed ID: 19013896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
    Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
    Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapies for soft-tissue sarcomas.
    Tap WD; Federman N; Eilber FC
    Expert Rev Anticancer Ther; 2007 May; 7(5):725-33. PubMed ID: 17492935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
    Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ
    BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapeutic targets for soft tissue sarcoma.
    Smith JL; Riedel RF
    Curr Oncol Rep; 2011 Aug; 13(4):350-8. PubMed ID: 21523334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas.
    Dela Cruz F; Matushansky I
    Discov Med; 2011 Oct; 12(65):307-17. PubMed ID: 22031668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.